GLS and fatty liver disease: Recent studies have highlighted the role of Gls in the context of metabolic dysfunction‐associated fatty liver disease (MAFLD), where it contributes to hepatic inflammation and fibrosis by promoting glutaminolysis‐mediated oxidative stress, T cell activation and cuproptosis—a newly described form of regulated cell death driven by copper accumulation [22].